Summit Therapeutics PLC ORD 1P

(LSE, Stocks) 
p 20.00
Updated 20/08/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 19,807
High P 19.80
Low P 19.00
Open P 20.00
Prev close P 20.00
# of shares 160.49M
Market cap 3,209.89M GBX

Summit Therapeutics PLC ORD 1P
Market is open (until 16:30) - Delayed 15 min
Price development Latest 1 week 1 month 3 months 6 months 1 year
  20.00 0.0% Stock price unchanged -15.8% Stock price decreasing -28.6% Stock price decreasing -7.0% Stock price decreasing -40.3% Stock price decreasing
Powered by TradingView

News about Summit Therapeutics PLC ORD 1P

  • English
  • Regulatory news

Company profile

Summit Therapeutics PLC is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of medicines for indications for which there inadequate or no therapies. It also conducts clinical programs focused on the genetic disease Cuchenne muscular dystrohy and the infectious disease Clostridium difficile infection. The company has drug development segment. Its all assets are located in the United Kingdom.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
22 August 2019 08:50:18
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB4 - 2019-08-22 09:50:18 - 2019-08-22 08:50:18 - 1000 - Website: OKAY